Table 2.
Demographic characteristics, risk factors and reported symptoms at onset in the retrospective population group
| VARIABLES | N = 226 | % |
|---|---|---|
| Mean age (years) ± standard deviation (SD) | 5.6 ± 5.2 | |
| Sex | ||
| M | 118 | 52.2 |
| F | 108 | 47.8 |
| RISK FACTORS/ANAMNESTIC DATA | ||
| History of Contact | 121 | 53.5 |
| Travel in high risk countries | 11 | 4.9 |
| Born in high risk country | 29 | 12.8 |
| Parents origin’s from high risk countries | 136 | 60.2 |
| Immunosuppression or immunosuppressive therapy | 4 | 1.8 |
| Antibiotic therapy | 92 | 40.7 |
| - With no benefit | 91 | 98.9 |
| Positive Quantiferon (analyzed before hospitalization) | 37 | 16.4 |
| Positive Mantoux (analyzed before hospitalization) | 94 | 41.6 |
| SIGNS/SYMPTOMS | ||
| Cough | 112 | 49.6 |
| Cough lasting ≥ 10 days | 49 | 21.7 |
| Fever | 104 | 46.0 |
| Fever lasting ≥ 10 days | 44 | 19.4 |
| Lymphadenopathy | 36 | 15.9 |
| Asthenia | 35 | 15.5 |
| Weight loss | 22 | 9.7 |
| Chest pain | 16 | 7.1 |
| Hemoptysis | 6 | 2.6 |
| Night sweats | 4 | 1.8 |
| DIAGNOSTIC TOOLS | ||
| Mantoux: positive ( +) (≥ 5 mm) | 210 | 92.9 |
| QTF + | 216 | 95.6 |
| Culture + | 86 | 42.2 |
| PCR + | 79 | 37.6 |
| Bacterioscopic + | 40 | 18.0 |
QTF Quantiferon, PCR Polymerase Chain Reaction